DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced that the first patient has ...
News Medical on MSN5d
Research points to correlation between preeclampsia and COVID-19 in pregnant womenDuring the COVID-19 pandemic, above all before vaccines were available, an alarm was sounded regarding a possible correlation ...
Women took the stand in an Idaho courtroom on Tuesday, testifying about their nonviable pregnancies under the state's total ...
One couple took out a loan to cover the out-of-network costs of an abortion and drove eight hours to a hospital in the ...
Doctors also told her that there were risks to her life and health -- including preeclampsia, hemorrhaging, high risk of miscarrying and risks to her fertility -- if she continued carrying the ...
DiaMedica Therapeutics (DMAC) “announced that the first patient has been dosed in DiaMedica’s investigator-sponsored Phase 2 trial ...
In fact, MINOCA was the diagnosis for nearly one in five women who developed ACS in the years following HDP, an overarching ...
Four women denied procedure take the stand Tuesday; Idaho OB-GYN testifies in case challenging Gem State’s ban ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback